“…Among the different parasite stages in the host, the schizont stage is the symptomatic stage, based on which attenuated schizont vaccines were designed. The cell culture-based attenuated vaccines have been used in countries, like India (Gupta et al, 1998), China (Zhang, 1997), Russia (Stepanova and Zablotskii, 1989), Turkey (Sayin et al, 1997), Spain (Viseras et al, 1997), Israel (Pipano and Tsur, 1966), Iran (Hashemi-Fesharki, 1988), Tunisia (Darghouth, 2008), and Morocco (Ouhelli et al, 1997) for controlling the T. annulata infection. The attenuation of the vaccine line because of the long term passage results in loss of genotypes, decreasing the diversity of the parasites (Darghouth et al, 1996;Pipano and Shkap, 2006;Bilgic et al, 2019).…”